ACTRN12607000571471终止3 期
A Pilot Study - Ziprasidone used as an Adjunctive Therapy in patients with Major Depressive Disorder: Impact on Symptoms and Functional Disability
Dr Nitin Dharwadkar0 个研究点目标入组 15 人开始时间: 2007年11月6日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 终止
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 55 Years（—）
- 性别
- All
入选标准
- •1. Patients with a diagnosis of Major Depressive Disorder (MDD) as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria
- •2. Aged 18 to 55 years old
- •3. A history during the current depressive episode of an incomplete or partial response to a trial of a selective serotonin reuptake inhibitors antidepressant (SSRIs), or a noradrenergic and specific serotonergic antidepressant (NASSA), at an adequate dose for a minimum of 6 weeks.
排除标准
- •1. Pregnancy
- •2. Lactation
- •3. Severe or unstable medical condition
- •5. Co-morbid diagnosis of any primary psychotic disorder or Personality Disorder
- •6. Co-morbid diagnosis of alcohol/substance abuse
- •7. Unable to obtain written informed consent.
研究者
相似试验
进行中（未招募）
1 期
Study to compare the efficacy of ziprasidone (Zeldox) and aripiprazole (Abilify) on cognitive functioning and quality of sleep in the treatment of schizophrenic patientsSchizophreniaEUCTR2005-004501-28-DEDepartment of Psychiatry, Ludwig-Maximilians-University Munich60
进行中（未招募）
不适用
Ensayo clínico con Ziprasidona para el tratamiento de la psicopatología no constituyente de un trastorno mental grave en la dependencia del alcohol - Ensayo con ziprasidona para el tratamiento de la paqtología psiquiátrica asociada al alcoholismoPatología psiquiátrica asociada al alcoholismoEUCTR2004-001056-36-ESInstitut de Recerca60
终止
3 期
Safety And Efficacy Of Ziprasidone In Adolescents With SchizophreniaSchizophreniaNCT00257192Pfizer's Upjohn has merged with Mylan to form Viatris Inc.284
已完成
3 期
Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)Bipolar DisorderNCT00257166Pfizer's Upjohn has merged with Mylan to form Viatris Inc.238
撤回
3 期
Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (Protocol A1281196)Bipolar DisorderNCT01117220Pfizer's Upjohn has merged with Mylan to form Viatris Inc.